Condition: Healthy Volunteers · Hepatic Impairment · Sponsor: Bristol-Myers Squibb
The purpose of this study is to determine the pharmacokinetic and safety of BMS-986435 in participants with normal hepatic function and participants with different degrees of hepatic impairment
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain the NCT# and Site #.
Always discuss trial participation with your own doctor first.
| Arizona Clinical Trials | Chandler, Arizona, United States | Recruiting |
| Panax Clinical Research | Miami Lakes, Florida, United States | Recruiting |
| Texas Liver Institute | San Antonio, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07248839